Frank Griesinger
Department of Haematology and Oncology
University of Göttingen
Germany
Name/email consistency: high
- A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia. Griesinger, F., Hennig, H., Hillmer, F., Podleschny, M., Steffens, R., Pies, A., Wörmann, B., Haase, D., Bohlander, S.K. Genes. Chromosomes. Cancer (2005)
- Secondary leukaemia after cure for locally advanced NSCLC: alkylating type secondary leukaemia after induction therapy with docetaxel and carboplatin for NSCLC IIIB. Griesinger, F., Metz, M., Trümper, L., Schulz, T., Haase, D. Lung. Cancer (2004)
- Identification of an ETV6-ABL2 fusion transcript in combination with an ETV6 point mutation in a T-cell acute lymphoblastic leukaemia cell line. Griesinger, F., Janke, A., Podleschny, M., Bohlander, S.K. Br. J. Haematol. (2002)
- Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome. Griesinger, F., Pirò-Noack, M., Kaib, N., Falk, M., Renziehausen, A., Troff, C., Grove, D., Schnittger, S., Büchner, T., Ritter, J., Hiddemann, W., Wörmann, B. Br. J. Haematol. (1999)